| scholarly article | Q13442814 |
| P356 | DOI | 10.1176/APPI.AJP.2008.08010129 |
| P8608 | Fatcat ID | release_ukp534c2b5e4nl7wdml2mmv5fu |
| P932 | PMC publication ID | 2859710 |
| P698 | PubMed publication ID | 18519533 |
| P5875 | ResearchGate publication ID | 51396128 |
| P50 | author | Daniel J Buysse | Q90217822 |
| P2860 | cites work | Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study | Q45186766 |
| An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia | Q46821951 | ||
| Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. | Q48288049 | ||
| Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression | Q48466179 | ||
| Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder | Q48506440 | ||
| Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. | Q48755706 | ||
| Clinical correlates of insomnia in patients with chronic illness. | Q48799115 | ||
| Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders | Q48834764 | ||
| Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? | Q52000509 | ||
| Residual symptoms in depressed patients who respond acutely to fluoxetine. | Q53933212 | ||
| Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia | Q34342604 | ||
| Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia | Q34482283 | ||
| National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. | Q34562330 | ||
| A systematic review of valerian as a sleep aid: safe but not effective | Q34579711 | ||
| Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). | Q34590065 | ||
| Symptom reports in severe chronic insomnia. | Q34768263 | ||
| The benzodiazepine site of the GABAA receptor: an old target with new potential? | Q35859251 | ||
| Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders | Q36170043 | ||
| Prevalence, course, and comorbidity of insomnia and depression in young adults. | Q36519093 | ||
| Insomnia as a risk factor for onset of depression in the elderly | Q38438197 | ||
| Epidemiology of insomnia: what we know and what we still need to learn | Q40610246 | ||
| Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy | Q41673576 | ||
| Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia | Q44679941 | ||
| Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia | Q44750287 | ||
| Functional neuroimaging evidence for hyperarousal in insomnia | Q45130119 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insomnia | Q1869874 |
| P304 | page(s) | 678-86 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Chronic insomnia | |
| P478 | volume | 165 |
| Q33880876 | Association between physical activity and insomnia symptoms in rural communities of southeastern Missouri, Tennessee, and Arkansas |
| Q34632507 | Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial |
| Q34887515 | Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescents |
| Q48312828 | How do pharmacists respond to complaints of acute insomnia? A simulated patient study |
| Q35027697 | Insomnia in adults: the impact of earlier cigarette smoking from adolescence to adulthood |
| Q37115893 | Pharmacotherapy for Insomnia in Primary Care |
| Q37188923 | Polysomnographic Sleep and Circadian Temperature Rhythms as a Function of Prior Shift Work Exposure in Retired Seniors |
| Q35892779 | Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? |
| Q47109567 | Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms. |
| Q34033307 | Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication |
| Q33561979 | Trouble sleeping inside: a cross-sectional study of the prevalence and associated risk factors of insomnia in adult prison populations in England |
| Q36779790 | ZolpiMist™: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US |
Search more.